例如:"lncRNA", "apoptosis", "WRKY"

Structure of an engineered multidrug transporter MdfA reveals the molecular basis for substrate recognition.

Commun Biol. 2019 Jun 17;2:210. eCollection 2019
Hsin-Hui Wu 1 , Jindrich Symersky 1 , Min Lu 1
Hsin-Hui Wu 1 , Jindrich Symersky 1 , Min Lu 1

[No authors listed]

Author information
  • 1 Department of Biochemistry and Molecular Biology, Rosalind Franklin University of Medicine and Science, 3333 Green Bay Road, North Chicago, IL 60064 USA.

摘要


MdfA is a prototypical H+-coupled multidrug transporter that is characterized by extraordinarily broad substrate specificity. The involvement of specific H-bonds in MdfA-drug interactions and the simplicity of altering the substrate specificity of MdfA contradict the promiscuous nature of multidrug recognition, presenting a baffling conundrum. Here we show the X-ray structures of MdfA variant I239T/G354E in complexes with three electrically different ligands, determined at resolutions up to 2.2 Å. Our structures reveal that I239T/G354E interacts with these compounds differently from MdfA and that I239T/G354E possesses two discrete, non-overlapping substrate-binding sites. Our results shed new light on the molecular design of multidrug-binding and protonation sites and highlight the importance of often-neglected, long-range charge-charge interactions in multidrug recognition. Beyond helping to solve the ostensible conundrum of multidrug recognition, our findings suggest the mechanistic difference between substrate and inhibitor for any H+-dependent multidrug transporter, which may open new vistas on curtailing efflux-mediated multidrug resistance.

KEYWORDS: Biochemistry, Structural biology